Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL

Medicine and Dentistry

• Phosphodiesterase 100%
• Cyclic AMP 83%
• Diffuse Large B-Cell Lymphoma 66%
• Combination Therapy 33%
• B Cell 33%
• Protein Tyrosine Kinase 16%
• Neoplasm 16%
• Phosphorylation 16%
• Programmed Cell Death 16%
• Mutant 16%

Biochemistry, Genetics and Molecular Biology

• B Cell 100%
• Phosphodiesterase 100%
• Cyclic Adenosine Monophosphate 83%
• Phosphorylation 16%
• Apoptosis 16%
• Tyrosine Kinase 16%
• Genetic Model 16%
• Mutant 16%